BCL2L13 anticorps (Middle Region)
Aperçu rapide pour BCL2L13 anticorps (Middle Region) (ABIN926875)
Antigène
Voir toutes BCL2L13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- BCL2 L13 antibody was raised in rabbit using the middle region of BCL2 13 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
BCL2L13 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this BCL2L13 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
-
Autre désignation
- BCL2L13
-
Sujet
- BCL2L13 May promote the activation of caspase-3 and apoptosis. Synonyms: Polyclonal BCL2L13 antibody, Anti-BCL2L13 antibody, BCL2-like 13, apoptosis facilitator antibody, BCL-RAMBO antibody, MIL1 antibody.
-
Pathways
- Positive Regulation of Endopeptidase Activity
Antigène
-